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ABSTRACT
Postoperative nausea and vomiting (PONV) causes distress and anxiety to the
pediatric patient. PONV can lead to dehydration, disruption of the incision site, delayed
discharge and cause unanticipated hospitalization after ambulatory surgery. The reported
incidence of PONV in children can be up to twice that of the adult patient. There are
many different strategies used in treating or preventing pediatric PONV including
pharmacologic, nonpharmacologic, homeopathic, and multi-modal therapies. Because of
the complex nature of PONV, it is necessary to approach its treatment with a rational
management. The purpose of this thesis was to compare different treatment techniques
for PONV on pediatric patients, by North Dakota certified registered nurse anesthetists
(CRNAs). The data was then compared with the PONV low and high-risk algorithms
created by Mott Children’s Hospital. These algorithms categorize pediatric surgical
patients into either low-risk or high-risk candidates for PONV. The algorithms are
evidence based and were formulated to reduce over and under use of antiemetics, promote
cost efficiency, and to promote the appropriate use of either single dose versus multi
modal therapy in treating pediatric PONV.
A survey was sent to all practicing CRNAs in North Dakota. The survey
questioned North Dakota CRNAs preventative, rescue, and treatment techniques for
pediatric PONV. The returned surveys were analyzed and compared to the Mott
Children’s Hospital algorithms. The results of this study showed minimal variation in
IX

practice among anesthesia providers in North Dakota as compared to the evidence based
Mott Children's Hospital algorithms. Variations were identified in the two areas of
gender and years of experience as a practicing CRNA. When studying the
appropriateness of treatment of pediatric PONV as compared to the Mott Children’s
Hospital algorithm, North Dakota CRNAs were treating pediatric patients appropriately.
Data were further analyzed using chi-square to identify if a difference occurred in
gender or years of experience when treating pediatric PONV. Analysis of the data
indicated that there was a relationship but it was not of significance.

x

CHAPTER I
INTRODUCTION
In children, postoperative nausea and vomiting (PONV) remains the leading cause
of morbidity after having surgery. Severe vomiting is associated with bleeding,
dehydration, electrolyte imbalances, wound dehiscence, and pulmonary aspiration. Even
mild PONV may result in a delayed hospital discharge with increased costs, as well as
decreased parental satisfaction, and an unpleasant experience for the patient (Munro,
2000).

Pediatric patients have twice the incidence of PONV as compared to adults.
Factors associated with increased PONV include age, sex, history of motion sickness or
previous PONV, surgical procedure and duration of procedure, and patient anxiety.
Infants have the lowest incidence of postoperative vomiting (POV), whereas preschool
children have an incidence of 20%. When considering children over the age of 13 years,
girls have a higher incidence of PONV than boys (Munro, 2000).
Unlike adults, children may not be able to describe the subjective feeling of
nausea. The endpoint in pediatric studies is usually limited to vomiting and retching.
Because drugs used to prevent nausea and vomiting have different effects on nausea and
vomiting, data from adults cannot be applied to children (Thompson, 1999).
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Significance of the Study
The ability to prevent PONV in the pediatric population requires that the
anesthesia providers understand the psychological, physiological, and pharmacological
causes and effects of PONV. The anesthetist must be able to identify the pediatric “at
high-risk for PONV patient,” and to identify causative factors. PONV has been shown to
cause increased length of stay, increased costs to the hospital and patient, and decreased
patient satisfaction to the surgical experience. This study sought to determine whether a
significant difference in treatment modalities amongst practicing CRNAs’ in the state of
North Dakota exists. Upon completion of the study, the purpose of this research was to
identify if North Dakota anesthetists are over-treating, under-treating, or appropriately
treating pediatric PONV, as compared to the evidence-based, Mott Children’s Hospital
algorithms.
Purpose of the Study
The purpose of this study was to compare North Dakota certified nurse
anesthetists (CRNAs’) treatment modalities for pediatric PONV to the Mott Children’s
Hospital algorithms for low-risk and high-risk PONV. The Mott Children’s Hospital
algorithms were created after doing a thorough literature review. These algorithms were
created for the management of patients with low (Appendix A) and high (Appendix B)
risk for PONV.
Many studies have been performed comparing costs, side effects, time of dosing,
and effectiveness of different agents. The complex nature of PONV necessitates a
rational approach to its management. The approach should involve all phases of the
patient’s hospital stay, with attention being paid to preoperative factors, anesthetic
2

management, attention in the postoperative care unit, and discharge instruction of the
pediatric patient. The survey evaluated how North Dakota CRNAs PONV treatment
compared with the algorithms developed by Mott Children’s Hospital for low-risk
(Appendix A) and high-risk patients (Appendix B).
Theoretical Framework
Nurse anesthetists with an understanding of the physiologic mechanisms involved
with nausea and vomiting can prevent and treat PONV with the appropriate
pharmacological agents. Nausea and vomiting are the body’s important, basic defense
mechanisms to prevent the ingestion and absorption of toxins, as well as response to
certain stimuli (Hansen, 1998, p. 701). Stimuli that may induce nausea and vomiting
include olfactory, visual, vestibular, and psychogenic (Munroe, 2000). With adequate
knowledge of pharmokinetics and triggering of nausea and vomiting, the nurse anesthetist
can properly intervene to prevent and treat nausea and vomiting.
“Nausea is an unpleasant subjective sensation resulting from conscious
recognition of stimulation of the vomiting centers in the medulla. Vomiting, also known
as emesis, is the sudden, forceful expulsion of the stomach contents” (Hansen, 1998,
p. 702). The reflex to vomit is located in the vomit center in the medulla, close to the
fourth ventricle. The vomit center has many inputs from multiple afferent sensory
pathways including cranial nerve X (the vagus nerve) cranial nerve VIII (the vestibular
nerve) the limbic system, and the chemoreceptors trigger zone (Thompson, 1999).
Stimulation of any of these areas, systems, or nerves may cause nausea and vomiting.
The vagus nerve relays sensory input from the mechanoreceptors and
chemoreceptors in the gastrointestinal tract, the respiratory tract, and the cardiovascular
3

system. The vomiting center is rich in neurotransmitters such as serotonin, dopamine,
histamine, and acetylcholine and these neurotransmitters relay this information. The
vestibular nerve (CN VIII) relays input from the auditory system. These receptors play a
role in this trigger. The limbic system appears to play a role in the learned response of
anticipated nausea and vomiting (Thompson, 1999). The blockade of these
neurotransmitters by specific drugs has been postulated to be the mechanism-of-action of
antiemetics.
In adult humans, nausea usually precedes vomiting, but not always. Vomiting,
the expulsion of gastric contents, is a reflex maneuver involving both visceral and striated
muscle. Vomiting occurs in reverse order of swallowing. The patient takes a breath
reflexively, the upper esophageal sphincter opens, the glottis and posterior nares close,
and the diaphragm and the abdominal muscles contract, producing emesis. Autonomic
nervous system signs associated with nausea include excessive salivation, dilated pupils,
tachypnea, swallowing, pallor, sweating, and tachycardia. Perioperative stimulation can
initiate the release of central nervous system emetogenic neurochemicals, thereby
initiating PONV (Hansen, 1998).
Persistent vomiting can result in dehydration, especially in the younger pediatric
population. Signs of visible dehydration in the pediatric patient include dry lips and
mouth, sunken eyes, tachypnea, tachycardia, decreased urine output, and sunken
fontanelle. Anesthesia providers need to treat dehydration in infants and smaller children
more aggressively. Recognizing these early or late signs of dehydration can facilitate a
better surgical experience and a timely recovery from surgery (Thompson, 1999).
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Several patient-related factors increase pediatric POV. Patients with previous
history of postoperative nausea and vomiting may trigger the chemoreceptor zone with
preoperative anxiety. The chemoreceptor zone is the highly vascular area postrema on
the surface of the brain. This area lacks a true blood brain barrier, with exposure to both
blood and cerebral fluid, and can thus react to substances in the blood (Thompson, 1998).
Pre-operative stimuli that increase the risk of POV in the pediatric patient include
patient-related factors such as age (greater than three years old to puberty), gender
(female, post-puberty), hormonal balance (post-puberty patient), weight (obesity), gastric
content (greater than 25 ml volume), prior experience of postoperative nausea and
vomiting, history of motion sickness, and anxiety. It is essential for the anesthesia
provider to identify the cause or origin of the nausea and vomiting (Watcha, 2004).
Research Questions
The following research questions were tested:
1. What impact does age, gender, and years of experience of North Dakota
CRNAs have on treatment of postoperative nausea and vomiting with the
pediatric population?
2. What are the variations in therapeutic modalities used by CRNAs’ in North
Dakota in treatment of pediatric PONV?
3. What are the considerations that affect North Dakota CRNAs’ decision to
treat pediatric PONV?
4. Are treatment modalities used by North Dakota CRNAs’ similar to the Mott
Children’s Hospital algorithms?
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Definition of Terms
For the purpose of this study, the following definitions of terms were used:
Nausea: “Nausea is an uneasiness of the stomach that often accompanies the urge
to vomit, doesn’t always lead to vomiting” (Cleveland Clinic, 2004).
Vomiting: A forcible voluntary or involuntary emptying of stomach contents
through the mouth. The abdominal muscles tighten against a relaxed upper stomach with
an open sphincter. The contents of the stomach are propelled up and out (Medline Plus,
2004).
Side-effects: Side-effects of antiemetics include extrapryamidal reactions,
hypotension, sedation, dry mouth, dysphoria, dizziness, and headache.
Low-risk: Pediatric patient at low risk for PONV has had no history of motion
sickness, no prior surgery, and are not having a surgery with high emetogenic potential.
High-risk: Pediatric patients at high-risk for nausea and vomiting include, prior
history of motion sickness, exposure to inhaled anesthetics (nitrous oxide), opioid
analgesics, surgery related factors (strabismus repair, tonsillectomy, gonadal operations,
oral or ENT procedures), and PACU-related factors (pain, vestibular imbalance,
decreased intravascular volume, hypotension, and hypoxia).
Assumptions
The following assumptions were made for this study:
1. CRNAs completing the survey will have had sufficient pediatric experience to
respond to the survey.
2. CRNAs will answer the survey honestly and to the best of their abilities.
3. CRNAs will understand the questions, and answer the survey completely.
6

Limitations
The following limitations were identified for this study:
1. CRNAs that responded to the survey may have had limited exposure to
pediatric patients.
2. The survey is limited to North Dakota CRNAs and the data may not be
transferable to other populations.
3. CRNAs are performing sufficient follow-up to identify whether or not patients
are experiencing PONV.
4. The responses of the non-respondents could have been greatly different from
those responses actually received.
5. Nausea is a subjective experience, which may not be reported or identifiable
by the pediatric patient, making it difficult for the CRNA to assess.
6. Controlling for extenuating circumstances is difficult in the operative setting,
and creates complexity in identifying which treatment modality is effective.
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CHAPTER II
REVIEW OF LITERATURE
Postoperative nausea and vomiting has been extensively studied in the adult
population. Unlike the adult population, the pediatric population has not received the
extensive evaluation of PONV. Since pediatric PONV continues to be the leading cause
of morbidity postoperatively, this area warrants further discussion and literature review.
Approaches to the treatment and prevention of PONV are numerous. Initially, the
anesthetist must be aware of preoperative, intraoperative, and postoperative factors that
can contribute to PONV for each individual patient. The financial implication of
treatment of PONV has always been a concern for hospitals. Many studies have been
done with regard to identifying the patient that warrants treatment and the drug(s) that
is/are effective. In addition, pharmacologic, nonpharmologic, and multi-modal
approaches to treatment and prevention of postoperative nausea and vomiting have been
extensively reviewed and studied. The review of literature focuses on the pediatric
population in regards to PONV.
Operative Factors
To identify whether or not a correlation existed, Wang and Kain (2000) studied
preoperative anxiety and PONV. Anxiety was assessed in the preoperative holding area
and upon induction of anesthesia. The researchers used a self-reporting behavioral
instrument to assess and score patient anxiety. They found that controlling for
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confounding variables, such as anxiety in the preoperative holding area, did not have any
predictive value for the occurrence of PONV.
Intra-operative factors that have been identified as risk factors for postoperative
nausea and vomiting include type of surgery, duration of surgery, and type of anesthesia.
Surgeries associated with high incidence of nausea and vomiting are adenotonsillectomy,
dental extraction, herniorrhaphy, orchiopexy, middle ear, and ophthalmic procedures
(Watcha, 2004). Children frequently have surgeries in these areas. “The longer the
duration of the operation and the longer the time for anesthesia, the risk increase for
nausea and vomiting” (Gan et al., 2003). Due to increased time to clear anesthesia from
the patients’ system, the risk of developing postoperative nausea and vomiting is
increased with longer anesthesia time.
The type of anesthesia used is also associated with increased risk. General
anesthesia has a higher risk than total intravenous anesthesia, or regional anesthesia.
Certain intravenous medications that are commonly used for induction of anesthesia have
been identified as causing PONV, such as opioids, etomidate, and ketamine. Newer
agents such as Propofol® seem to exert an anti-emetic effect. Research on the inhalation
anesthetic agent nitrous oxide is inconclusive (Drake et al., 2001).
Postoperative factors that affect nausea and vomiting include pain, hypotension,
oral intake, movement, and opioid analgesia. Pain is a known factor in postoperative
nausea and vomiting. With the relief of pain, patients usually have the sensation of
nausea subside. Hypotension from sympathetic blockade, fluid restriction, blood loss, or
anesthetics have been shown to induce nausea. The restriction of oral intake until the
return of bowel function has also been shown to delay, and possibly to decrease, the
9

incidence of postoperative nausea and vomiting. The use of opioid analgesics increases
postoperative nausea and vomiting, but the use of ketorolac, a nonsteroidal anti
inflammatory, has been proven to decrease the affect of PONV (Rose & Watcha, 1999).
Cost
Despite advances in pharmacology, PONV continues to be a common occurrence,
which incurs large hospital costs. Studies evaluating the pharmaco-economics of
antiemetics used for the prevention and treatment of POV in children are limited. Older
antiemetics, such as anticholinergics and dopamine-receptor antagonists, are less
expensive than newer agents such as serotonin (5-HT3) receptor antagonists (Watcha,
2004).
Determination of the costs of an anti emetic regimen should include: drug
acquisition cost, pharmacy supply cost, and costs associated with managing therapy
failure (i.e., additional treatment costs, such as costs of resources for emesis cleanup,
labor costs, and lost caregiver income because of a patient’s prolonged illness). Only a
few analyses studies have been done using these cost indicators (Watcha, 2004).
Olutoye, Jantzen, Alexis, Rajechert, Shreiner, & Watcha studied the cost
effectiveness of two 5-HT3 blockers, granisetron and ondansetron. Thee study had two
goals, to find the smallest, effective dose of granisetron, and to compare costs of
managing POV dolasetron to treatment with ondansetron. The smallest, effective dose
for granisetron was 350 mcq/kg, which was more cost-effective than the use of
ondansetron. The study showed that prophylactic treatment with either drug was equal,
but granisetron was more cost-effective than ondansetron. “Since it is difficult to assess
patient satisfaction in the pediatric population, the outcome of cost-effectiveness must be
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must be weighed against what common sense tells the provider in doing the right thing
for the pediatric patient” (Olutoye, 2003).
Carroll et al. (1999) noted that in the outpatient surgical center, the average cost
of treating a patient for prevention of PONV was $14.94. The estimated per-patient
treatment cost to surgical centers for patients who experienced PONV was $415. This
cost reflects personnel wages, supplies and drugs, increased length of stay in the post
anesthesia unit, and the backlog created on the operating room schedule. In addition to
the increased cost of postoperative nausea and vomiting, the pediatric patient may
develop life-long fears and dissatisfaction with the surgical experience. Some adult
patients have stated that the postoperative nausea and vomiting was more disabling than
the operation itself (Thompson, 1998).
Pharmacologic
Known as antiemetics, pharmacologic agents work by blocking the receptors
involved in the process of vomiting. The four receptors that are blocked by
chemoreceptor trigger zone drugs include serotonin, dopamine, cholinergic, and
histamine. Drugs that block these receptors are called serotonin type 3 (5-HT3) receptor
blockers, anticholinergics, antihistamines, and dopamine receptor blockers. Many studies
have been performed on antiemetic drugs to evaluate both their effectiveness and sideeffects. Depending on the dosage of the drug used, the side effects can increase or
decrease. Common side-effects include extrapyramidal reactions, hypotension, sedation,
dry mouth, dysphoria, dizziness, and headache (Gan, Meyer, Apfel, Chung, Davis,
Eubanks, Kovac, Philip, Sessler, Temo, Tramer, & Watcha, 2003). Extrapyramidal
reactions are identified as symptoms that resemble parkinsonian syndrome. These
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symptoms are characterized by restlessness, oculogyries, bradykinesia, muscle rigidity,
akathisia, and acute dystonic reactions (Hansen, 1998).
“The ideal antiemetic would be effective, free of side effects, and inexpensive”
(Gan, 2003). Nurse anesthetists must be aware of the latest research regarding antiemetic
therapy and PONV. For prevention and treatment of PONV, pharmacologic studies have
been done comparing drug dose, drug effectiveness, cost, and timing of the dose
administration. Many of the studies were specific to certain high-risk surgeries for the
pediatric patient.
Serotonin Receptor Antagonists
Serotonin (5-HT3) receptor antagonists such as ondansetron, granisetron, and
dolasetron produce antiemetic activity by selectively inhibiting 5-HT3 receptors located
in both the central and peripheral nervous system. Because they are effective and
relatively free of side-effects and sedation, the development of these drugs are considered
a major advancement in pediatric POV. The most common reported side-effect was
headache and dizziness. Because 5-HT3 receptor antagonists are more effective in
preventing vomiting than preventing nausea, these drugs are considered to be the drugsof-choice for treating prophylaxis of POV in children (Munroe, 2000).
Patel, Davis, Orr, Ferrari, Rimar, Hannallah, Cohen, Colingo, Donlon, Haberkern,
McGowan, Prillaman, Parasuraman, and Creed (1997) studied the use of single-dose
ondansetron (Zofran®) for prevention of PONV in pediatric outpatient. The study
evaluated the safety and efficacy of ondansetron compared to placebo in prevention of
PONV. This study concluded that ondansetron effectively prevented PONV in pediatric
patients undergoing outpatient surgical procedures associated with high risk
12

postoperative vomiting. In addition, prophylactic use of ondansetron was found to reduce
the time to reach criteria for home readiness and time to discharge from the facility.
Watcha, Bras, Cieslak, and Pennant (1995) studied the dose response relationship
of the antiemetic ondansetron in preventing postoperative emesis in pediatric patients
undergoing ambulatory surgery. Before this study, dosing had been based on
chemotherapy-induced emesis, which was 100-150 mcq/kg. The study concluded that a
dose of 50 mcg/kg was as effective as a larger dose of lOOmcq/kg. Using the smaller
dose showed decreased side-effects from the antiemetic such as extrapryamidal reactions.
Since ondansetron is the most expensive antiemetic currently on the market, this smaller
dosing is significant in that it may be more cost-effective to both the patient and the
hospital, if multi-dose vials are used.
Sadhasivam, Shende, and Madan (2000) studied the prophylactic use of
ondansetron in prevention of PONV following pediatric strabismus surgery. In children,
strabismus repair is associated with the highest incidence of PONV - as many as 88% of
patients that do not receive antiemetics will experience PONV. The researchers stated
that patient comfort or satisfaction is one of the most important true outcome measures of
surgery. With total elimination of PONV, any improvement in patient satisfaction with
prophylactic antiemetics is a worthwhile treatment. Because of its benefits in terms of
effectiveness and safety, the researchers felt that cost containment should not be an issue
when treating the pediatric patient. Until a safer, better, and more cost-effective
alternative is available, this study concluded that routine, prophylactic treatment with
ondansetron is justified.
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Cieslak, Watcha, Phillips, and Pennant (1996) studied the dose-response relation
and cost-effectiveness of granisetron for the prophylaxis of pediatric PONV. In a
randomized, double-blind, placebo-controlled study, 97 pediatric outpatients received a
10 to 40 meg intravenous dose of placebo or granisetron during standardized anesthetic.
Granisetron provided effective prophylaxis in children against PONV, but only with the
larger dose. Granisetron was shown to reduce significantly the incidence of PONV when
administered at higher doses. Granisetron has a prolonged duration of action with a
single dose, so patients who received this drug had decreased emesis for the 24-hour
period post anesthetic, which also offset cost of therapy. The dose required to treat
PONV was higher than the Food and Drug Administration recommended dose for
emesis. The researchers reported that further studies needed to be conducted that would
include cost, patient satisfaction and preferences, in addition to efficacy.
Dopamine Receptor Antagonists
Dopamine receptor antagonists that are effective in preventing and treating
pediatric POV include the benzamides (metoclopramide), butyrophenones (droperidol),
and phenothiazines (promethazine and perphenazine). Each of these agents exerts an
antiemetic effect, primarily by blocking dopamine receptors in the chemo-trigger zone
(Kovac, 2000).
Droperidol has proven efficacy in the prevention and treatment of POV in
children. Recent reports of electrocardiogram rhythm changes with the use of droperidol
led the FDA to insert a black box warning in the package insert. The initial report was
based on the usage of large doses (>25 mg) for management of manic depressant patients.
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The warning emphasized that the use of benzodiazepines, volatile anesthetics, and
opioids increases the risk of prolonged QT syndrome (White, 2002).
Granisetron-droperidol drug combination to prevent PONV in children was
studied by Fujii, Tanaka, and Toyooka (1999). Since droperidol is a dopamine receptor
blocker, and granisetron, like ondansetron, is a serotonin (5-HT3) receptor blocker (also
known as antiserotonin agents), they have differing side-effects. Droperidol is associated
with the side-effects of excessive sedation, hypotension, dry mouth, dysphoria,
restlessness, and extrapryamidal symptoms. The new agents of 5-HT3 blockers are more
expensive, but have very few side-effects. Granisetron is the only new oral agent of 5HT3 blockers available. The researchers found the combination to be more effective than
single drug therapy for PONV, covering two different areas in the vomiting center.
Although phenothiazines are primarily CNS dopamine-receptor antagonists, they
also have modest anticholinergic and anti-histiminergic effects. These drugs are effective
in preventing and treating POV by countering the effects of drugs that stimulate the
chemo-trigger zone. Adverse effects of phenothiazines include extrapyramidal effects
and sedation (Kovac, 2000). These adverse affects may complicate postoperative care, or
prolong hospitalization, limiting their use in POV prophylaxis (Rose, 1999).
Fujii, Toyooka, and Tanaka (1998) compared oral granisetron to phenothiazine
for the reduction of PONV after tonsillectomies in children. One hundred and eighty
pediatric patients, aged 4 to 10 years, were enrolled in a prospective, randomized, double
blind investigation, and assigned to one of three treatment regimens: granisetron,
compazine, or granisetron plus compazine. Noting that the cost difference between
granisetron and compazine may be a factor for hospital choice of antemetic drugs, the
15

researchers concluded that preoperative oral granisetron was more effective than
compazine. As of this writing, oral granisetron is $12.60 per dose, and oral compazine is
$0.90 per dose; therefore, using granisetron may be considered cost prohibitive.
Anticholinergic Agents
Anticholinergic agents are potent inhibitors of cholinergic and muscurinic
receptors located in the nucleus of the solitary tract and vestibular apparatus. Adverse
affects of anticholinergic agents is dry mouth, visual disturbances, sedation, dysphoria,
and hallucinations (Kovac, 2000). The typical anticholinergics used in the pediatric
population are atropine and glycopyrrolate.
Neuromuscular blockade, which is often required in surgery, is reversed with
anticholinestrases, such as neostigmine or edrophoneum. Neostigmine must be given in
combination with the anticholinergics, such as atropine or glycopyrrolate, to prevent
severe bradycardia or sinus arrest. Chibber, Lustik, Thakur, Francisco, and Fickling
(1999) studied the effects of anticholinergics on PONV, recovery, and hospital stay in
children undergoing tonsillectomy with or without adenoidectomy. The researchers
found that in children undergoing tonsillectomy, reversal of neuromuscular blockade with
atropine and neostigmine is associated with a lesser incidence of PONV, compared with
glycopyrrolate and neostigmine.
Antihistamine Agents
Antihistamines block histamine receptors in the nucleus of the solitary tract and
acetylcholine in the vestibular apparatus (Kovac, 2000). These drugs may be effective in
preventing or controlling emesis following vestibular stimulation, which occurs during
middle ear surgery and postoperative motion sickness, but their overall weak antiemetic
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properties and the profound sedation caused by antiemetics make these drugs less suitable
for the management of POV. The consensus guidelines for management of POV does
not recommend the use of antihistamines in the treatment of PONV (Gan, 2003).
Steroids
Cortical steroids exert antiemetic properties by a mechanism that is yet unknown.
Proposed mechanisms include prostaglandin antagonism, endorphin release, reduction in
serotonin levels in the brain and gastrointestinal tract, anti-inflammatory, and membranestabilization effects (Watcha, 2004). Studies have been conducted either with steroids
given alone, or in combination with other antiemetics.
Aouad, Siddik, Rizk, Zaytoun, and Baraka (2001) studied the effect of
dexamethasone, a corticosteroid, on post-tonsillectomy PONV. This study compared
early and late vomiting, time to first oral intake, quality of oral intake, satisfaction scores,
and duration of IV hydration. The overall incidence of vomiting, as well as the incidence
of late vomiting, was significantly less after the administration of dexamethasone. The
time to first oral intake and the duration of IV hydration were shorter after
dexamethasone was given. Due to this procedures high risk for PONV, the researchers
recommended dexamethasone be given to pediatric patients prior to tonsillectomy
surgery.
Children undergoing tonsillectomies are at particular risk because of the location
of the surgical site, and increased incidence of swallowing blood and secretions. Splinter
and Roberts (1997) conducted a study comparing two drugs, dexamethasone and
promethazine, for vomiting after tonsillectomy. The researchers chose these two drugs to
study because they are relatively inexpensive antiemetics that decrease vomiting after
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tonsillectomies. When analyzing the data, the researchers noted that there was an
increase in POV when inhaled anesthetics were used over total IV induction with
propofol. Propofol is an induction agent used by anesthesia that acts by mimicking
GABA action. Other actions include a rapid, pleasant recovery, and antiemetic effects.
More female patients were found to have complications of POV than males. Further
investigation was suggested to determine whether this was a spurious result of genuine
observation. They found that droperidol was more effective than dexamethasone before
discharge from the hospital but that the two drugs had similar effects after discharge.
Nonpharmacologic
Nonpharmacologic drugs for PONV can be used effectively as preventative
measures. Nonpharmacologic treatments that have shown effectiveness in prevention of
PONV are acupuncture, electroacupuncture, and hypnosis. Acupuncture, a Chinese form
of medicine, is thought to prevent nausea and vomiting, but the mechanism is not clear.
Its effectiveness may be related to release of endorphins, adjustment of autonomic nerves,
and improvement in motility of the intestines and stomach. The P6 acupressure point,
used by acupuncturists, is located in an area on the forearm that with application of
pressure has been found to be effective for prevention of motion sickness and PONV.
These methods of reducing PONV in the pediatric population have not received a lot of
study (Gan et al., 2003).
In 2002, Rusy, Hoffman, and Weisman conducted a study using
electroacupuncture for prophylaxis of PONV following pediatric tonsillectomy. The
researchers found that this nonpharmacologic method did reduce PONV in the awake
pediatric patient that received acupuncture, but did not reduce the incidence of PONV
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when used as a rescue antiemetic. This study also questioned the appropriateness of
using this method for the pediatric population.
The ability to tolerate fluids is a common criterion for discharge from day
surgery; however, requiring children to drink oral fluids is also thought to exacerbate
PONV. Kearney, Mack, and Entwistle (1998) withheld oral fluids from children who had
undergone outpatient surgery to study the affect of PONV. The researchers found that
withholding oral fluid was well tolerated, inexpensive, did not contribute to increased
hospital stay or unanticipated admission, and markedly decreased vomiting in patients
requiring opioids perioperatively. The practice of requiring pediatric patients to take oral
intake prior to discharge was removed from the discharge criterion at the researchers’
facility at the conclusion of the study.
Multimodal/Combination Therapy
Because several neurochemicals receptors are involved in the pathogenesis of
emesis, using a combination regimen for preventing POV is a rational approach.
Many practitioners are using a multi-modal PONV management protocol. Simple
techniques such as >80% inspired oxygen, adequate intravenous fluids, avoiding nitrous
oxide and neuromuscular blocking agent, and propofol should be used. The surgeon may
perform a procedure in which local anesthesia is infiltrated over the surgical site. This
procedure improves pain management, which decreases PONV. In addition, giving
ketorolac at the end of surgery has been proven effective in decreasing PONV by
minimizing postoperative pain (Scuderi et al., 1999).
Gan et al. (2003) studied the multimodal approach that was the closest to
eliminating nausea and vomiting postoperatively. They stated that a multimodal
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approach to treatment of PONV should be used when high-risk patients are identified.
Emetogenic stimuli, such as pain, motion, or a noisy environment should be avoided or
reduced. Therapy may include anxiolytics (benzodiazepines such as Versed), adequate
IV hydration, withholding of oral fluids, prophylactic antiemetics (consider combination
therapy), total IV anesthesia (with Propofol), effective anesthesia with local anesthesia,
nonsteroidal anti-inflammatory drugs (with ketorolac), supplemental oxygen, and
nonpharmacologic techniques such as acupuncture, electro-acupuncture, hypnosis.
Drake, Anderson, Persson, and Thompson (2001) studied the impact of an
antiemetic protocol on PONV in children. The researchers introduced an antiemetic
protocol aimed for PONV management in which 272 children were enrolled in the study:
138 in Group 1, and 134 in Group 2. There was a difference between the two groups for
gender, type of surgery, perioperative opioid, and perioperative antiemetic use. The
protocol aimed to rationalize prescribing based on cost, with the least expensive drug
being used. The study showed that the introduction of an antiemetic protocol for
symptomatic management of PONV made a positive result impact on the severity of
symptoms.
Because many studies have had contradictory conclusions concerning one
effective regimen, not all research on pediatric PONV has been in agreement on an exact
treatment protocol. The medical staff at Mott Children’s Hospital created two algorithms
for treating low- and high-risk pediatric PONV that have been found to be effective:
these researchers found that routine prophylaxis for all surgical patients was not
necessarily indicated. If a pediatric patient is considered low-risk (Appendix A),
traditional antiemetics such as droperidol for treatment of PONV and ondansetron for
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rescue should be used; however, those children in the high-risk group (Appendix B) who
had a previous history of PONV, motion sickness, strabismus or tonsillectomy surgery,
should be treated with a more cautious approach.
A rational plan for a child in a high-risk group should include the intake of fluids
up to two hours preoperatively, a benzodiazepine premedication, and the use of a regional
technique when appropriate. If general anesthesia is necessary, consider using propofol
and/or total intravenous anesthetic, use sevoflurane as the inhaled agent, if needed,
avoiding nitrous oxide, and opioid. The use of nonsteroidal anti-inflammatory agents
when possible, and other local anesthetic wound infiltration or regional nerve blocks was
preferred. Combination antiemetics should be administered prophylactically (i.e.
ondansetron, droperidol, and/or dexamethasone) (Munro, 2000).
A cost-analysis has shown that the more expensive drug, ondansetron, is only
cost-effective if the frequency of emesis exceeded 33%, whereas prophylactic droperidol
is cost-effective if the frequency of emesis is 10%. If prophylactic antiemetic medication
fails, a drug from a different class should be administered. In addition, the treatment of
established PONV is more difficult, especially if it occurs after hospital discharge. It is
important to treat pain and dehydration, and to avoid other precipitating factors such as
oral intake, movement, etc. In the event that all of these interventions fail, hospital
admission may be necessary (Munro, 2000).
Postoperatively, patients should emerge from anesthesia in a quiet environment,
well-hydrated, and free of pain. In addition, patients should avoid early oral intake and
movement; should PONV occur, a drug from a different class that has not already been
used should be prescribed. Given a rational approach to the management of PONV,
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reducing the unpleasant side-effects of anesthesia to low levels in children undergoing
surgery should be possible (Munro, 2003).
Summary of Literature Review
A multitude of studies have been performed comparing different drugs from
similar pharmacologic classes and other pharmacologic classes. More recent research has
focused on a multimodal technique. The focus has turned to not only treating PONV but
also preventing PONV prior to the occurrence. The research includes identifying
pediatric patients at risk, treatment preoperative, and avoiding triggering factors. This
rational approach to pediatric PONV was used in studying North Dakota CRNAs’
treatment of pediatric PONV.
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CHAPTER III
METHODOLOGY OF THE STUDY
Introduction
Chapter III presents the methodology of this quantitative, comparative study. The
study was conducted using a survey sent out to all North Dakota Certified Registered
Nurse Anesthetist. The following research questions were answered in this chapter.
The research questions that were answered include:
1. What impact does age, gender, and years of experience of North Dakota
CRNAs have on treatment of postoperative nausea and vomiting in the
pediatric population?
2. What are the therapeutic modalities used by CRNAs in North Dakota to
treating pediatric PONV?
3. What are the considerations that affect CRNA’s decision on how to treat
pediatric PONV?
4. Will the treatment modalities for CRNAs in North Dakota with regards to
treating pediatric PONV be similar to the Mott Children’s Hospital
algorithms?
The population, sample, study design, data collection, instrument reliability and
validity, and protection of human subjects are presented.
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Population and Sample
The population and sample for this study consisted of practicing North Dakota
certified registered nurse anesthetists. A list of the CRNA’s of North Dakota was
obtained from the North Dakota Board of Nursing. A survey asked specific questions
pertaining to prevention, treatment, and rescue practices for pediatric postoperative
nausea and vomiting. The results of the study were specific to pediatric population. All
participants received the same survey.
The surgical procedures specifically identified were tonsillectomy, middle ear,
strabismus, abdominal, inguinal hernia, and orthopedic. In this study, the survey
documented North Dakota CRNA’s treatment modalities, and the efficiency of treatment
options. The results were then compared to the Mott Children's Hospital algorithms for
treatment of low-risk and high-risk pediatric patients for PONV. The medical staff at
Mott Children’s Hospital created two algorithms for treating low and high risk pediatric
PONV that have been found to he effective. Treatment for all pediatric patients was not
necessary. The indication for treatment was identified for patients that fall into either
low- or high-risk categories. If a pediatric patient is considered low-risk (Appendix A),
then traditional antiemetics such as droperidol for treatment of PONV and ondansetron
for rescue should be used. However, those children in the high-risk group (Appendix B)
such as previous history of PONV, motion sickness, strabismus or tonsillectomy surgery,
should be treated with a more cautious approach.
Study Design
The study was a non-experimental, exploratory, descriptive survey. The data
were obtained from North Dakota CRNAs regarding their practice of treating and
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preventing pediatric PONV. Information was collected to compare the North Dakota
CRNAs practice to Mott Children’s Hospital algorithms for treating pediatric PONV. To
analyze the treatment options of the North Dakota anesthetists, a questionnaire was
created by the researcher. The relationship to the Mott Children’s Hospital algorithms
was explored to determine whether or not differences in practice techniques exist. The
same investigator reviewed all questionnaires that were returned.
Data Collection Method
North Dakota nurse anesthetists were sent a survey and cover letter informing
them of the intentions of this researcher. These anesthetists were mailed this survey with
a stamped return envelope to maintain anonymity. The data collection period was from
when the survey was sent out in September 20, 2004, to November 30, 2004. In the
cover letter (Appendix E), the participants were informed of the purpose and procedure of
the study. In the survey (Appendix F), the participants were asked their years of
experience, gender, frequency of working with pediatric patients, status of employment,
use of prophylactic antiemetics, incidence of PONV after anesthesia, medications
administered to avoid PONV, surgeries that were routinely treated for PONV, and
effectiveness of medications that were used. One advantage of using a questionnaire
included the ability to elicit attitudes, beliefs, and opinions; a second advantage included
incorporation of a large sample size. Lastly, less bias is reported when comparing
questionnaires with interviews.
Instrument Reliability and Validity
The best tool limits error in measurement. In order to maximize reliability and
validity of the survey tool, a pilot-group, an anesthesia instructor, and the chairperson of
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the researcher’s thesis committee were used to evaluate the questionnaire. The pilotgroup used for this purpose consisted of an anesthesia professor, a doctoral professor of
research nursing, and eleven first-year anesthesia students - all from the University of
North Dakota. Recommendations were taken into account to improve the survey and
revisions were made in conjunction with the group’s input. The data obtained from the
pilot group were not included in the survey results.
Data Analysis
Data analysis was completed to address the research questions of the study. The
analysis for this study involved descriptive analysis of the data gathered through the
survey tool. A coding guide was developed for data entry. Each survey was numbered
and data was analyzed. Statistical Package for the Social Sciences (SPSS®) and an
Excel® spreadsheet were used to provide statistical results. Since data were collected
from one population, chi-square and ANOVA were used to compare the significance in
nominal variables of gender, years of experience, status of employment (full-time, parttime, and locum), and factors affecting decision to treat pediatric PONV. For the entire
study, the level of statistical significance (p-value) was set at 0.05. A two-tailed test was
used to test for statistical significance in ratio variables.
Protection of Human Subjects
Institutional Review Board (IRB) approval was obtained from the University of
North Dakota. The subjects involved in this study were not asked to identify themselves.
This data collected will be locked and stored in the nursing building on the University of
North Dakota campus in a locked cabinet for three years, and after that time, the
information will be destroyed. In order to obtain additional information in regard to this
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study (if they so desired), the participants were given the researcher’s name and address,
the researcher’s advisor, Dr. Julie Anderson's name and telephone number, as well as the
University of North Dakota’s Institutional Research Board telephone number. The cover
letter (Appendix E) containing this information served as the consent for the study. A
stamped, self-addressed envelope was sent with each survey. There was no identified
risk to the subjects of the study; data was reported in aggregated format.
The benefits of participating in the study include the participants’ reflection of
their own practice, which may lead to a more beneficial behavior in anesthesia care. This
may lead to future changes in the practice of participating CRNAs.
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CHAPTER IV
RESULTS
Nurse anesthetists with an understanding of the physiologic mechanisms involved
with nausea and vomiting can prevent and treat PONV with the appropriate
pharmacological agents. With adequate knowledge of pharmokinetics and triggering of
nausea and vomiting, the nurse anesthetist can properly intervene to prevent and treat
nausea and vomiting.
The vomiting center is rich in neurotransmitters such as serotonin, dopamine,
histamine, and acetylcholine and these neurotransmitters relay this information. These
receptors play a role in this trigger (Thompson, 1999). The blockade of these
neurotransmitters by specific drugs has been postulated to be the mechanism-of-action of
antiemetics. With the use of this physiologic framework, CRNAs can better treat
pediatric PONV.
The purpose of this study was to evaluate North Dakota CRNAs treatment of
pediatric postoperative nausea and vomiting. Since pediatric postoperative nausea and
vomiting continues to be the leading cause of morbidity postoperatively, CRNAs need to
be aware of low and high risks for pediatric PONV. Mott Children’s Hospital algorithms
have a rational approach to the treatment of PONV. The surveys of North Dakota
CRNAs were compared against the Mott Children’s Hospital algorithms.
The following research questions addressed in this study:
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1. What impact does age, gender, and years of experience of North Dakota
CRNAs have on treatment of postoperative nausea and vomiting in the
pediatric population?
2. What are the variations in therapeutic modalities used by CRNAs’ in North
Dakota in treatment of pediatric PONV?
3. What are the considerations that affect North Dakota CRNAs’ decision to
treat pediatric PONV?
4. Are treatment modalities used by North Dakota CRNAs’ similar to the Mott
Children’s Hospital algorithms?
The population of this research project consisted of all currently licensed North
Dakota CRNAs. Of the 150 surveys sent, 145 were delivered, and five surveys were
returned to the sender due to change of address; of the 145 that were delivered, 117 were
returned to the researcher, which produced an 81% return rate. Two participants were
excluded secondary to failure to complete the survey entirely, and four others were
excluded due to return of their surveys after data were analyzed. Therefore, the total
number of surveys analyzed was 112.
Collected data were analyzed using chi-square; a significance level of p - .05 was
used for this study. Demographics of this study included 62 female respondents, and 50
male respondents. Descriptive statistics were used to answer the research questions
presented in this paper. The gender, frequency-of-working in North Dakota, and
frequency of providing pediatric anesthesia are shown in Table 1. Frequency-of-working
was broken into three categories of part-time, full-time and locum, the categories being
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rare (less than one patient per week), occasionally (at least one patient per week), and
frequently (more than one patient per week).
Table 1. Demographics of Study

N

%

Female

62

55.4

Male

50

44.6

Full-time

95

84.8

Part-time

7

6.3

10

8.9

Rarely (cone pt/wk)

24

21.4

Occasionally (one pt/wk)

48

42.9

Frequently (>one pt/wk)

40

35.7

Characteristics

Gender

Work in North Dakota

Locum
Frequency

Number of months that the CRNA’s had worked as a locum in North Dakota
varied from one month to five months each year. The mean years worked of all the
CRNAs that responded to the survey were 14 years, ranging from one year to 37 years.
The first research question, what impact does age, gender and years of experience
of North Dakota CRNAs have on treatment of postoperative nausea and vomiting in the
pediatric population, was addressed using the chi-square analysis. Where sample data of
nominal scaling are from one population, the chi-square test-of-independence is a used to
test a null hypothesis that the attributes of the elements of a given population are not
related (Mann, 2004). Gender of North Dakota CRNAs was obviously separated into
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male and female categories. The difference in gender between male and female CRN As
was not significant (chi-square test = 9.449, df = 4, p = 0.5).
Years of experience was also studied to identify if number of years practicing as a
CRN A affected one’s choice to treat pediatric PONV. The difference in years of
experience was divided into four categories: new CRNA (five years of experiences, or
less); intermediate CRNA (six to nine years of experience); advanced (ten to fifteen
years); and expert (greater than 15 years experience). Chi-square was run on this data
and the results indicated that CRNAs who treated PONV and years of experience are not
related.
The research question, “Were treatment modalities used by North Dakota CRNAs
similar to the Mott Children’s Hospital algorithms?” (Appendix A and B), was analyzed.
The Motts Children's Hospital algorithms were created after doing a thorough literature
review. These algorithms were created for the management of pediatric patients with
both low-risk PONV (Appendix A), and high-risk PONV (Appendix B). The Mott
Children’s Hospital algorithms indicate that not all children require treatment for PONV,
and both the low- and high-risk patients must be identified.
The North Dakota CRNAs were questioned on the frequency of PONV in the
pediatric population that they serve. The incidence of pediatric PONV was divided into
rarely (less than 25 % of the patients), occasionally (approximately 50% of the patients),
and frequently (greater than 75% of the patients). Table 2 represents those results.
Giving medications prior to the incidence of having nausea and vomiting is
termed prophylactic treatment. North Dakota CRNAs reported prophylactically treating
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their pediatric patient with antiemetics 75% of the time. The results of the survey
question are listed in Table 3.
Table 2. Frequency of Pediatric PONY in Treated Population.

n

%

Rare (<25% of pts)

74

66.1

Occasionally (50% of pts)

14

12.5

Frequently (>75% of pts)

3

2.7

21

18.8

Incidence of PONY

Unsure

Table 3. Prophylactic Treatment of Pediatric Patients for PONY.

N

%

Rarely (<25%)

17

15.2

Occasionally (50%)

20

17.9

Frequently (>75%)

75

67.0

Prophylactic Treatment

Not clearly defined by the collected data, the analysis of the second research
question, “What are the variations in therapeutic modalities used by CRNAs in North
Dakota in treatment of pediatric PONY?” was addressed by the survey question
regarding treatment techniques. The survey requested that the CRNAs check all of the
techniques used when they were concerned with PONY in the pediatric patient. The five
treatment options listed were: total intravenous anesthesia, extra intravenous fluids,
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ketorolac, rather than opioids, premedication with anxiolytics, and high concentration
oxygen. All of the options are from the Motts Children’s Hospital high risk for PONV
algorithm (Appendix B) The data were categorized into the total number of responses
the CRN A chose from the list provided on a scale from one to five. Table 4 shows these
results of the treatment options.
Table 4. Techniques Used for Treatment of Pediatric PONV.

Number of Treatment Tech.

N

%

1

29

25.9

2

43

38.4

3

21

18.8

4

11

9.8

5

6

5.4

Of the 112 respondents, only six appropriately responded to all choices as options
they would use to treat pediatric PONV.
The third research question, “What are the considerations that affect North Dakota
CRNAs’ decision to treat pediatric PONV?” was addressed by the survey question of
how the anesthetic plan is derived and limitations of antiemetic availability. The
anesthetic plan to treat pediatric postoperative nausea and vomiting was divided into
three separate categories: independently, in collaboration with the anesthesiologist, or in
collaboration with the surgeon. Despite the request to answer the survey questions with
one response, six survey respondents answered the question with more than one answer.
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Consequently, these six surveys were not compiled into the data. The anesthetic plan to
treat PONV is listed in Table 5.
Many factors play a role in the limitation of CRNA for treatment options. The
limitations were divided into four different categories: hospital limitation of drug
availability, time restraints to give adequate preoperative antiemetics, MD
preference/limitation, and having no limitation of antiemetic treatment of pediatric
PONV. Table 6 display those results.
Table 5. Anesthetic Plan to Treat Pediatric PONV.

N

%

Independently

66

58.9

Collab.with Anesthesiologist

33

29.4

Collab. with Surgeon

7

6.3

Plan

Table 6. Limitation of CRNAs Treatment Options for Treatment for Pediatric PONV.

N

%

41

36.6

2

1.8

MD preference/limitation

16

14.3

No limitation

53

47.3

Limitation
Hospital Limitation
Time Restraints
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In addition, in answering the research question, “Are treatment modalities used by
North Dakota CRNAs’ similar to the Mott Children’s Hospital algorithms?” the
following survey question was asked, according to high-risk surgeries. The CRNAs were
asked how they prophylactically treat pediatric patients for PONV in accordance to both
high- and low-risk surgeries. The surgeries chosen are surgeries that are commonly
performed in North Dakota hospitals. The high-risk surgeries included tonsillectomy,
middle ear, and strabismus. The low-risk surgeries include abdominal, inguinal hernia,
and orthopedic. Respondents were asked how frequently they medicated for each
surgery, according to the following percentage classifications: rarely (<25%),
occasionally (50%), often (>75), or not at all. Table 7 shows the responses of treatment.
Table 7. Surgeries that ND CRNAs Prophylactically Treat for PONV.

Surgeries
Rare

Frequency
Occas. (50%) Often (>75%)

Never

Tonsillectomy

5

13

90

4

Middle Ear

10

7

84

11

Strabismus

7

12

78

15

Abdominal

12

24

63

13

Inguinal Hernia

15

26

59

12

Orthopedic

17

30

50

15

Other

8

3

7

94

Additional information collected from the survey is listed in Tables 8, 9, and 10.
Tables 8 - 1 0 indicate medications that were used for prophylactic, intraoperative, and
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rescue therapy for pediatric PONV. In table 8, the data was summarized to relate the
number of times they prophylactically treated their pediatric patients with each of the
following drugs. The categories for each column for the next three tables were all broken
down into either rare (less than 25% of the patients), occasionally (50% of the patients),
often (greater than 75% of the patients), or never.
Table 8. ND CRNAs Prophylactic Treatment of PONV.

Medication

Rare (<25%)

Frequency
Often (>75%)
Occas. (50%)

Never

Dexamethasone

12

29

63

8

Ondansetron

11

19

54

28

Droperidol

37

9

9

57

Granisetron

23

12

27

50

Metoclopramide

32

19

7

54

Scopolamine

34

4

2

72

8

1

14

89

Other

Table 9 reports how effective the anesthetist found each of the drugs they used on
pediatric PONV to be. This information is subjective and reports the perception of the
anesthetists’ feelings about each of the drugs.
In Table 10, the results of the information of what drugs CRNAs used to treat for
rescue pediatric PONV. In the write in portion of this category, anesthetists frequently
provided information stating they did not frequently treat rescue PONV. The
anesthesiologist treated rescue PONV.
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Table 9. ND CRNAs Found These Medications to be Effective for Pediatric PONY.

Medication

Rare (<25%)

Frequency
Often (>75%)
Occas. (50%)

Never

Dexamethasone

4

23

70

15

Ondansetron

5

8

73

26

Droperidol

12

9

26

65

Granisetron

14

11

27

60

Metoclopramide

12

24

10

66

Scopolamine

16

9

4

83

7

2

10

93

Other

Table 10. ND CRNAs Use These Medication for Rescue Pediatric PONY.

Medication

Rare (25%)

Frequency
Often (>75%)
Occas. (50%)

Never

Dexamethasone

21

9

22

60

Ondansetron

10

16

42

44

Droperidol

22

12

16

62

Granisetron

17

14

7

74

Scopolamine

0

0

0

0

Other

7

4

8

93
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CHAPTER V
SUMMARY, DISCUSSION AND RECOMMENDATIONS
The purpose of this study was to evaluate North Dakota CRNAs treatment of
pediatric postoperative nausea and vomiting. This chapter will summarize the findings of
the study, discuss further research necessary, and provide recommendations for research,
policy, education, and practice of pediatric PONV. A conclusion of that analysis is
presented in this chapter.
Summary
Postoperative pediatric nausea and vomiting continues to be a significant problem
for anesthesia providers. Pediatric postoperative nausea and vomiting can also cause
other, significant complications with morbidity and mortality; consequently, anesthesia
providers are constantly striving to prevent and treat these complications. Many studies
have been conducted on antiemetics, which identified factors such as history of previous
postoperative nausea and vomiting or motion sickness, anesthetic technique, type of
surgical procedure, and length of surgery should be considered during the analysis of the
risk of PONV in pediatrics.
A rational plan for each child in the low- and high-risk categories should be
anticipated. With a rational approach to the management of PONV, it should be possible
to reduce this unpleasant side effect of anesthesia to low levels in children undergoing
surgery.
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Recommendation for Education
It is important that anesthesia providers remain current with their understanding
of new, antiemetic drugs; accordingly, they must be aware of the drugs that are affective
for rescue versus the drugs that are affective for prophylactic treatment. The results of
this study will be presented at the spring, 2005 North Dakota anesthesia conference.
Recommendation of Practice
Since pediatric, postoperative nausea and vomiting continues to be a major
concern in the anesthesia field, the practice of treating postoperative nausea and vomiting
in the pediatric population must be continually evaluated until the problem is minimized,
or alleviated altogether. As CRN As gain insight on how they can improve their care,
their practice will continually develop. Sharing the results of studies in such areas as in
hospital staff meetings and at annual anesthesia conferences, will help CRNAs make
educated choices when it comes to treating pediatric postoperative nausea and vomiting.
In several North Dakota facilities, the survey identified that the anesthesiologist
performed both the preoperative and postoperative visits with the pediatric patients, and
the CRNAs provided the anesthesia to the patients. CRNAs of North Dakota reported
that sufficient follow-up communication between the anesthesiologist and the anesthetist
was not consistently occurring to identify patients that experienced PONV. This led the
researcher to recommend a paradigm of better, postoperative follow-up communication
by the CRNA, or better communication between the disciplines was in order.
Recommendation of Policy
It was found through an extensive literature review, that following an algorithm to
identify pediatric patients at low or high risk for postoperative nausea and vomiting
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would create a more unified approach to treatment. Identifying risks for PONV is the
initial part of treatment. Mott Children’s Hospital algorithms list causative factors that
place pediatric patients at risk. Recommendation is made to implement a policy for
practice of treating pediatric PONV, using research based algorithms, such as ones
created by Mott Children’s Hospital.
Recommendation of Research
Recommendation for future research might include surveying the pediatric patient
population - both postoperative and upon discharge - from the hospital. Frequently,
pediatric patients may have PONV after discharge from a same-day procedure, and the
anesthesia provider will be unaware of the event.
Also of interest would be to survey anesthesiologists, who frequently perform
postoperative visits. The survey should include questions to identify how thoroughly
they evaluate postoperative nausea and vomiting, and how the follow-up information is
disseminated back to the CRNAs who provided the anesthesia to the pediatric patient.
To evaluate if anesthesia providers are treating postoperative nausea and vomiting
differently in other regions of the country, this study should be administered to different
regions of the United States. Respondents were not asked the question about the
background of their education. The same “school-of-thought” may be taught to
practicing CRNAs in regards to treating pediatric PONV, depending on were they
received their graduate education. Even though the data obtained from this study may, or
may not be generalized nationally, the survey questions confirmed this by the fact that all
North Dakota CRNAs used at least one of the treatment techniques suggested by Mott
Children’s Hospital algorithms for treatment of suspected (high-risk) postoperative
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nausea and vomiting in the pediatric patient. In addition, North Dakota CRNAs reported
that 66% of the time, their pediatric patient rarely had PONV.
Upon completion of the study, it was found that North Dakota anesthetists are not
over-treating, under-treating, but are appropriately treating pediatric PONV, as compared
to the evidence-based, Mott Children’s Hospital algorithms. The Mott Children’s
Hospital algorithms for low-risk and high-risk PONV algorithms were created after doing
a thorough literature review for the management of patients with low (Appendix A) and
high (Appendix B) risk for PONV. Over-treating of pediatric PONV can create
unnecessary increased cost, drug interactions, and side effects to the patients. Under
treatment may cause extended hospital stay, increased hospital charges, and an
unpleasant experience for the pediatric patient. The data obtained indicated that there
was no significant difference in the treatment modalities of North Dakota CRNAs from
the Mott Children’s Hospital Algorithms.
Since pediatric postoperative vomiting continues to the leading cause of
morbidity after surgery, it must continue to be a serious consideration in the practice of
anesthesia. The anesthetist must be able to identify pediatric patients at low or high risk
for PONV and understand how to best treat each individual patient. The North Dakota
CRNAs all had made some type of effort in regards to treatment of pediatric PONV but
continued improvement should always be the goal.
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APENDIX A

MOTT CHILDREN'S HOSPITAL LOW-RISK ALGORITHM

P RE OPERATIVE
LOW RISK FOR PONV

Fig 1. Prevention and treatm ent of pediatric P O N V low -risk algorithm . T raditional antiem etics include the follow ing: droperidol
10 to 20 /xg/kg, in traven ou sly (IV) (m ax 0.625 mg); m etoclopram ide 0.15 m g/kg, IV (m ax 10 mg); trim eth ob en za m id e 100 m g, per
rectum (PR) (children le ss than 14 kg) or 100 to 200 m g, PR (children m ore than 14 kg); prom ethazine 0.25 to 0.5 m g/kg, IV or PR
(m ax 25 mg); prochlorperazine 0.13 m g/ kg in tram uscu lar (IM ) (m ax 10 m g; not in children le ss than 20 lb s or le ss than 2 years of
age). Reprinted w ith p e rm issio n from C.S. M o tt C h ild re n 's Hospital, A n n A rbor, M l
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APPENDIX B

MOTT CHILDREN’S HOSPITAL HIGH-RISK ALGORITHM

Fig 2. Prevention and treatment of pediatric P O N V high-risk algorithm. Traditional antiemetics include the following: droperidol
10 to 20 pg/kg, intravenously (IV) (max 0.625 mg); metoclopramide 0.15 mg/kg, IV (max 10 mg); trim ethobenzam ide 100 mg, per
rectum (PR) (children less than 14 kg) or 100 to 200 mg, PR (children m ore than 14 kg); prom ethazine 0.25 to 0.5 mg/kg, IV or PR
(max 25 mg); prochlorperazine 0.13 m g/kg intram uscular (IM) (max 10 mg; not in children less than 20 lbs or le ss than 2 years of
age). Reprinted with perm ission from C.S. M ott C hildren's Hospital, A n n Arbor, Ml.
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APPENDIX C

QUESTIONNAIRE COVER LETTER

September 20, 2004
Mary Bidegaray
323 4th St NE
Sidney, MT 59270
Dear North Dakota CRNA’s,
My name is Mary Bidegaray, and I am a graduate student at the University of
North Dakota currently completing my Master of Science Degree in Nursing with a
specialization in anesthesia. As part of my thesis requirements, I am engaged in a study
concerning the treatment of postoperative nausea and vomiting (PONV) in the pediatric
population.
Your name was selected from a list of active CRNAs in the state of North Dakota.
I hope that you will be able to complete this important survey. This study will take
approximately 5 minutes of your time to complete. I hope you find the questions
interesting. Please complete the questions in the order in which they are presented. You
have the right to skip any questions you do not wish to answer, and you may stop
completing the questionnaire at any time you wish without penalty. I hope, however, that
you will complete the survey in its entirety. There are no right or wrong answers. Please
be as truthful as possible. Your answers are completely confidential. Please do not put
your name on the questionnaire and no one will know how you answered the items. The
returned questionnaires will be locked and stored in the nursing building on the UND
campus, then destroyed after a period of no less than three years. Only the researcher,
advisory, and IRB auditor will have access to the data. The results will be summarized in
my final thesis paper. Your consent to participate will be assumed by your completion
and return of the enclosed questionnaire.
If you have any questions feel free to contact me at (303)905-0935 or my
chairperson, Dr. Julie Anderson at (701)777-4541. If you have any other questions,
please contact the Office of Research and Program Development at (701 )777-4279. In
addition, if you are interested in an abstract of my results, feel free to contact me at the
above address or the below via email address.
Thank you for your time and assistance.
Sincerely,

Mary Bidegaray,
mary.bidegaray@und.nodak.edu
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APPENDIX D

QUESTIONNAIRE

Survey for North Dakota CRNAs
Please check the correct answer:
My gender is
______ Female
______ Male
I have worked as a CRNA for
______ years
I work in North Dakota as a CRNA
______ Full-time
______ Part-time
______ Locum
If locum, please give number of months per year working in North Dakota_________________________
I provide anesthesia to pediatric patients
______ Rarely (less than one patient per week)
______ Occasionally (at least one patient per week)
______ Frequently (more than one patientper week)
I make my anesthetic plan to treat pediatric PONV
______ Independently
______ In collaboration with the anesthesiologist
______ In collaboration with the surgeon
I am limited on which antiemetics I use for my pediatric patients by
______ Hospital limitation of drug availability
______ Time restraints to give adequate preoperative antiemetics
______ MD preference/limitation
______ I have no limitation of antiemetics I use for pediatric PONV
I prophylactically treat my pediatric patients with antiemetics
______ Rarely (<25%)
______ Occasionally (50%)
______ Frequently (>75%)
The incidence of nausea and vomiting in the pediatric population I service is
______ Rare (less than 25% of the patients)
______ Occasionally (approximately 50% of the patients)
______ Frequently (more than 75% of the patients)
______ Unsure
I use the following techniques when I am concerned with PONV in the pediatric patient (Please check all
that apply)
______ Total intravenous anesthesia
______ Extra IV hydration
______ Ketorolac rather than opioids
______ Premedication with anxiolytic (midazolam)
______ High concentration oxygen
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Please indicate for which type of pediatric surgical procedure(s) that you currently treat prophylactically for
PONV:
Surgeries
Frequency
Rare (<25%)
Occasional (50%)
Often (>75%)
Tonsillectomy
____________
______________
___________
Middle ear
____________
______________
___________
Strabismus
____________
______________
___________
Abdominal
____________
______________
___________
Inguinal hernia
____________
______________
___________
Orthopedic
____________
______________
___________
Other
____________
______________
___________
Please explain:_______________________________________________________

Medication(s) I would choose for prophylactic treating pediatric PONV:

Medication

Frequency

Rare (<25%)
Occasional (50%)
Often (>75%)
Dexamethasone (steroid)
____________
______________
____________
Ondansetron (5HT-3 blocker) ____________
______________
____________
Droperidol (Dopa receptor)
____________
______________
____________
Granisetron (5Ht-3 blocker)
____________
______________
____________
Metoclopramide (prokinetic) ____________ ____________________ __________________
Scopolamine (anticholinergic) ____________
______________
____________
Other
____________
______________
____________
Please explain:__________________________________________________________________

I find that these medication(s) are effective for pediatric PONV:
Medication
Effective
Rare (<25%)
Occasional (50%)
Often (>75%)
Dexamethasone
___________
______________
___________
Ondansetron
___________
______________
___________
Droperidol
_____________________________________________
Granisetron
___________
______________
___________
M e t o c l o p r a m i d e ______________________________
___________
Scopolamine
___________
______________
___________
Other
___________
______________
___________
Please explain:_________________________________________________________

I use these medications for pediatric PONV rescue therapy:
Medication
Frequency
Rare (<25%)
Occasional (50%)
Often (>75%)
Dexamethasone
___________
______________
___________
Ondansetron
___________
______________
___________
Droperidol
___________
______________
___________
Granisetron
____________________________________________
Metoclopramide
___________
______________
___________
Scopolamine
___________
______________
___________
Other
___________
______________
___________
Please explain:_________________________________________________________
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